Breast Cancer

  • Ibrance 2018 report

    Ibrance 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Ixempra 2018 report

    Ixempra 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Kadcyla 2018 report

    Kadcyla 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 19 Pages The 5 Key Questions Addressed by this Report:...

  • Kisqali 2018 report

    Kisqali 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Lynparza 2018 report

    Lynparza 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Nerlynx 2018 report

    Nerlynx 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Perjeta 2018 report

    Perjeta 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Talzenna 2018 report

    Talzenna 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Verzenio 2018 report

    Verzenio 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Abraxane 2017 report

    Abraxane 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 27 Pages The 5 Key Questions Addressed by this Report:...

  • Afinitor 2017 report

    Afinitor 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 30 Pages The 5 Key Questions Addressed by this Report:...

  • Avastin 2017 report

    Avastin 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 25 Pages The 5 Key Questions Addressed by this Report:...